for 129 ovarian cancer patients failing prior chemotherapy , overall clinical response rates were : 21 % with cisplatin , 36 % with cisplatin plus doxorubicin , 52 % with cyclophosphamide added to the two drugs , and 44 % with hexamethylmelamine added to the three drugs .
C0008838
cisplatin
C0279212
cisplatin